Market access platform for primary care portfolios

See exactly how your products are listed across the NHS, at any moment.

Vima Access keeps eyes on every product in your portfolio across all six NHS data sources. Our specialists check every panel each quarter, flag anything that’s drifted, and work alongside your team to put it right.

6
NHS data sources covered
dm+d, clinical systems, wholesalers, the Drug Tariff, prescribing data, formularies
42
ICBs covered
ready for the 2026 mergers
Weekly
dm+d scans
Vima Access checks for changes to your products
Quarterly
Specialist verification
Vima Clinical, every panel, every product
02The problem

Misalignment is rare. When it happens, you find out too late.

Most of the time, your products are correctly listed across dm+d, the clinical systems, the wholesalers and the Drug Tariff. The problem isn’t frequency. It’s that when something drifts, no system tells you. By the time you find out from a field rep or your sales numbers, the damage is usually done.

What changes silently

A clinical system marks your product discontinued by mistake. A wholesaler catalogue lags behind dm+d. The Drug Tariff revises a price. An ICB formulary updates without anyone telling you.

How teams find out today

A field rep calls in from a prescriber. A pharmacist complains. A sales dashboard misses forecast. Often, nobody finds out for months. The loss is silent.

What it costs

A launch quarter goes sideways. A mature product slowly loses scripts. Brand reputation takes a hit, one prescription at a time. The exact figure is unknowable, which is the problem.

The only defence is to keep looking. That’s what Vima Access does.

+
03What we monitor

Every product. Every NHS data source. Every quarter.

Six panels per drug. Each one shows what’s been verified, when, and by whom. Our specialists check every panel each quarter; dm+d and prescribing data refresh automatically.

01Product informationdm+d-linked names, identifiers, strengths, packs, pricing, classification. Refreshed automatically each week.dm+d · weekly
02Clinical system listingsListing state across EMIS Web, TPP SystmOne, Vision and ProScript Connect. Per-pack, with search-term coverage.Curated · quarterly
03Wholesaler listing auditCatalogue name, PIP code, listed price across AAH, Alliance, Phoenix. Brand-policy aware (excluded vs monitored).Curated · quarterly
04ReimbursementDrug Tariff category, list price, ACBS approval, monthly price concessions. Per pack.Drug Tariff · monthly
05Prescribing trendsNational and ICB-level monthly items, brand-aware aggregation across strengths.NHSBSA EPD · monthly
06ICB formulary statusRAG classification per ICB, with prescriber-level restrictions and source URL. 42 ICBs covered.Curated · quarterly
+
04For your portfolio

The products you launched years ago, still bringing in volume.

Mature products in your portfolio get less attention. Brand teams move on. Field teams focus on launches. But the NHS systems don’t pause, and when something drifts on a product nobody’s watching, you find out from the field months later. Vima keeps eyes on every product.

01
We watch your whole portfolio

Every product on the platform, not just the ones launching. dm+d, clinical systems, wholesalers and the Drug Tariff all monitored on a regular cycle.

02
We flag the moment something drifts

When a clinical system flips a product to discontinued, a wholesaler delists a pack, or the Drug Tariff revises a price, your MA lead sees it surfaced on the platform with full context.

03
Our specialists help you fix it

When intervention is needed, we draft NHSBSA queries, contact wholesalers and Optum, and work alongside your team. You stay in charge. We make you more effective.

05For launches

Weekly verification, throughout the launch window.

When a new product or pack lands, the NHS systems take weeks to update across the board. During a launch, Vima checks each panel weekly for the first 12 months. You know when your product is live in each prescribing system, which wholesaler hasn’t picked it up yet, and where the slip-risk really is.

Milestones complete themselves

When the underlying panels update, related milestones close automatically. Manual entry only for milestones that don’t have an underlying data source.

Slip-risk warnings rooted in real lag patterns

NHSBSA submission windows, clinical-system listing lags, wholesaler stocking patterns. The platform flags when reality drifts from the expected cadence.

Daily morning digest

Every watched launch, every morning. What’s progressed, what’s at risk, what changed in the last 24 hours.

06How it works

The platform shows. Specialists verify.

Vima is two layers. The platform shows what each NHS source says about your products, with full provenance and history. The Vima Clinical team verifies findings, drafts NHSBSA correspondence on your behalf, and works with your market access lead to resolve drift when it surfaces. Your team stays in charge. We make them more effective.

Always available
The platform

Pulls dm+d weekly and NHSBSA prescribing monthly, fully automated.

Holds every panel's history with full provenance and last-verified-by.

Surfaces drift on dm+d and prescribing data the same day it appears.

On the work
Vima Clinical specialists

Verify flagged drift, distinguish noise from real issues.

Draft NHSBSA queries, contact wholesalers and Optum on your behalf.

Quarterly verification cycles across every panel, every SKU.

In charge
Your team

MA lead owns the function. We extend it; we don't replace it.

You decide what to escalate and sign off on actions.

Brand teams and launch PMs get visibility through the same platform.

+
07Behind the platform

“After years working on NHS primary care market access, the same gap kept showing up. Nobody was checking every product, every quarter, across every NHS source. When something drifted, it was always found too late. Vima Access is the platform we always wished existed.”

Vima Clinical LtdFounded by pharmacists with NHS market access experience.
Decades
of UK pharma market access experience on the team.
42
ICBs covered, ready for the 2026 mergers.
Every pack
checked separately, not aggregated to drug level.
Quarterly
verification cycle on curated rows, with a named verifier.
08Pricing

Custom-quoted per portfolio.

We charge for what we actually monitor: the platform, the SKUs in your portfolio, and the launches you have in flight. No per-seat fees. No surprise onboarding charges.

01Platform feeThe platform itself: dashboards, alerts, account management, quarterly review calls.Annual · flat
02Per-SKU monitoringQuarterly specialist verification across all six NHS data sources, per pack. Optional ICB formulary coverage for the SKUs that need it.Annual · per SKU
03Per-launch monitoringWeekly verification across every panel for the 12-month launch window, then drops to the standard rate automatically.One-off · per launch

A pooled specialist support package is included in every contract. Exact rates depend on portfolio shape and contract length — tell us about yours and we’ll come back with a number.

See your portfolio in Vima Access.

Tell us which products you’d want to see and we’ll prepare a tailored demo with real data, typically within five working days.

No marketing spam. We’ll respond within two working days.